.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Optic neuritis is not a single disease entity. It can occur as part of multiple sclerosis, neuromyelitis optica spectrum disorder, MOG-antibody disease or other inflammatory disorders, and the treatment implications differ. This 2024 evidence review summarises contemporary diagnosis and management, including the role of MRI and disease-specific antibody testing. A key practical message is that atypical optic neuritis—such as severe bilateral disease, prominent disc swelling, unusual age or poor recovery—should trigger consideration of alternatives to typical MS-associated optic neuritis. High-dose corticosteroids remain central to acute treatment, while plasma exchange is considered when recovery is inadequate in severe inflammatory cases. The review also highlights that long-term relapse prevention depends on identifying the underlying disorder correctly. For HCPs, an apparent optic neuritis diagnosis should therefore trigger careful phenotyping rather than automatic labelling as MS. Accurate distinction between MS, NMOSD and MOGAD can determine prognosis, acute treatment intensity and maintenance therapy. The topic fits IANCON's dedicated neuro-ophthalmology workshop and its emphasis on visual field interpretation, OCT, pupils and neuro-ophthalmic signs in special scenarios.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Optic neuritis is not a single disease entity. It can occur as part of multiple sclerosis, neuromyelitis optica spectrum disorder, MOG-antibody disease or other inflammatory disorders, and the treatment implications differ. This 2024 evidence review summarises contemporary diagnosis and management, including the role of MRI and disease-specific antibody testing. A key practical message is that atypical optic neuritis—such as severe bilateral disease, prominent disc swelling, unusual age or poor recovery—should trigger consideration of alternatives to typical MS-associated optic neuritis. High-dose corticosteroids remain central to acute treatment, while plasma exchange is considered when recovery is inadequate in severe inflammatory cases. The review also highlights that long-term relapse prevention depends on identifying the underlying disorder correctly. For HCPs, an apparent optic neuritis diagnosis should therefore trigger careful phenotyping rather than automatic labelling as MS. Accurate distinction between MS, NMOSD and MOGAD can determine prognosis, acute treatment intensity and maintenance therapy. The topic fits IANCON's dedicated neuro-ophthalmology workshop and its emphasis on visual field interpretation, OCT, pupils and neuro-ophthalmic signs in special scenarios.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
